# ImmuneSensor Therapeutics, Inc. — Form D

ImmuneSensor Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-05. The offering totals $20.0M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-12-05
- Form: D
- Accession: 0001956825-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $10.0M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2022-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466598

## Issuer

- Name: ImmuneSensor Therapeutics, Inc.
- CIK: 0001956825
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2110 RESEARCH ROW, DALLAS, TX, 75235
- Phone: 469-387-5398

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Zhi Hong | Director | Dallas, TX |
| Qingsong Li | Director | Dallas, TX |
| Ernest Wong | Director | Dallas, TX |
| Ning Zhang | Director | Dallas, TX |
| Qingsong Li | Executive Officer | Dallas, TX |
| Ernest Wong | Executive Officer | Dallas, TX |

## More

- [CIK 1956825 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1956825&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001956825-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.